In January 2024, a Silicon Valley venture firm best known for early checks into Airbnb and Stripe agreed to buy a hospital. Not a health-tech app. Not a software vendor selling to hospitals. An actual, 130-year-old, brick-and-mortar health system in Akron, Ohio, with acute-care beds, an insurance arm, and roughly $850 million in debt. When the deal finally closed in 2025, General Catalyst became the first venture capital firm to own and operate a hospital. Almost nobody in the industry saw it as a one-off.
That single move captures what General Catalyst has become. Founded in 2000, it is one of the older names in American venture capital, yet it is also one of the strangest to define today. It still writes seed checks. It still backs growth-stage rockets. But it also builds companies from scratch, runs its own operating businesses, and increasingly behaves like a holding company for the systems it thinks society can't do without. The firm has a word for all of it: resilience.
01 / The originEntrepreneurs investing in entrepreneurs
General Catalyst started in Cambridge, Massachusetts, a short walk from MIT and Harvard, launched by four operators - Joel Cutler, David Fialkow, Bill Fitzgerald, and David Orfao - who had built and sold companies before they ever managed a fund. The founding pitch was almost a slogan: "entrepreneurs investing in entrepreneurs." The idea was that people who had actually run companies would be more useful to founders than people who had only studied them.
For most of its first two decades, that looked like a very good, very conventional venture firm. It was early into Airbnb, Stripe, Snap, HubSpot, Kayak, Warby Parker, Gusto, Canva, and Samsara - the kind of roster that puts a firm on every founder's shortlist. What changed was not the taste. It was the ambition about what a venture firm is allowed to be.
Most venture firms spot the winner and wait for the exit. General Catalyst decided to create the company, buy the customer, and own the infrastructure.
The shift under CEO Hemant Taneja02 / The turnWhen a fund starts acting like a platform
Hemant Taneja became CEO in 2021, and the firm he reshaped is noticeably different from the one he joined. He consolidated General Catalyst's US, European, and Indian operations into a single global entity, folding in Germany's La Famiglia and India's Venture Highway rather than running them as loose affiliates. Then he pointed the whole thing at a thesis he calls "global resilience": the belief that AI will touch every industry, and that the smart move is to invest in the critical systems underneath modern life - healthcare, defense and intelligence, energy, industrials, and finance - rather than only the consumer apps on top.
The structure follows the thesis. General Catalyst still runs classic programs it labels Create, Seed, and Grow. But it added a Customer Value Fund that hands proven companies non-dilutive capital to spend on customer acquisition, a company-creation arm that hatches startups internally, a policy-focused GC Institute, and operating businesses that don't look like funds at all. HATCo - short for the Health Assurance Transformation Corporation - is the clearest example, and it is the vehicle that ended up owning a hospital.
03 / The hospitalWhat HATCo actually did in Ohio
Summa Health is not a startup. It is a nonprofit system that has served Akron and Canton for more than 130 years, with acute-care hospitals, a rehab facility, community medical centers, physician offices, and its own insurance arm, SummaCare. It was also carrying heavy debt. General Catalyst's HATCo agreed to acquire it, initially valued at $485 million; Ohio's attorney general approved the deal with conditions, including lifting the price to roughly $515 million.
The economics are as unusual as the premise. The transaction, combined with the system's cash on hand, let Summa eliminate around $850 million in debt - nearly its entire load - and convert to a for-profit structure under HATCo's ownership. HATCo also pledged $350 million over the first five years for routine operations and technology. In return, General Catalyst gets something no other investor has: a real health system to use as a live testbed, where it can trial technology from its own portfolio companies and push toward value-based care alongside a network of about 20 partner health systems.
It is the first hospital operator owned by a venture capital firm - and General Catalyst treats it as a proving ground, not a trophy.
On the Summa Health acquisition04 / The moneyAn $8 billion fund, sliced on purpose
In October 2024, General Catalyst announced Fund XII at $8 billion, its largest raise ever. The way it was split is more revealing than the headline number. Roughly $4.5 billion went to the firm's core venture funds, $1.5 billion to its company-creation strategy, and $2 billion to separately managed accounts. A dedicated $750 million was earmarked for health assurance. Read the allocation and you can read the firm's convictions: a big classic-venture engine, a serious commitment to building companies rather than only funding them, and healthcare treated as its own category.
The firm's business model has quietly stretched to match. It still earns management fees and carried interest like any fund. But value now also accrues through equity in some 900 companies, through the non-dilutive Customer Value Fund, and through the operating performance of businesses it controls outright. That is a hybrid few investors attempt - part venture firm, part company builder, part holding company - and it is why "what is General Catalyst, exactly?" has become a genuinely hard question to answer in one sentence.
05 / The portfolioFrom consumer darlings to defense
The names tell the story of the shift. Alongside the consumer and SaaS classics sit companies that map directly to the resilience thesis: Anduril in defense, Ramp in fintech, Mistral AI and Glean in applied AI, Samsara in industrial operations. General Catalyst has been public about backing "ethically responsible" defense and intelligence companies, an area many venture firms avoided for years. Put the portfolio next to the fund allocation and the direction is consistent - toward the industries that governments and institutions, not just consumers, depend on.
A selection of General Catalyst investments across consumer, SaaS, fintech, AI and defense.
06 / The problemWhat it is actually trying to fix
Strip away the structure and the firm keeps returning to the same complaint: the industries that matter most are the ones venture capital historically underserved. Healthcare is expensive and reactive - what General Catalyst calls "sick care" rather than care. Defense procurement is slow and dominated by incumbents. Energy, industrials, and manufacturing were written off for years as too capital-heavy and too unglamorous for software money. The firm's answer is to treat AI as the lever that finally makes those sectors investable, and to supply not just capital but market access, policy expertise, and, when useful, an operating business the startups can build against. Owning Summa Health is the extreme version of that logic: if you want to prove healthcare software works, it helps to control the hospital.
The expertise that makes this plausible is less financial than operational. The partnership was founded by people who ran companies, and the firm has deliberately staffed itself with industry veterans, physicians, defense hands, and technical builders rather than pure investors. That mix is what lets it credibly hatch companies internally and run a health system - work most funds would never attempt.
07 / The customersWho this is actually for
General Catalyst's primary customers are founders - at seed, at growth, and increasingly ones the firm helps start itself. Its other customers are its limited partners: the institutions, endowments, sovereign funds, and family offices that supplied that $8 billion and expect returns. The Summa acquisition adds a third, less familiar constituency: patients and providers, served directly through an operating business the firm now runs. It is rare for a single organization to answer to founders, fund investors, and hospital patients at the same time.
We are early in an AI transformation that will touch every industry, institution, and life.
General Catalyst, on its worldview08 / The market positionBigger than a fund, narrower than a bank
In the league table of global multistage investors, General Catalyst sits alongside Andreessen Horowitz, Sequoia, Lightspeed, Insight Partners, Founders Fund, and Thrive Capital. What separates it is less the check size than the willingness to own operations. Where a16z built a media and services machine around its funds, General Catalyst has gone a step further and bought a hospital. Whether that is visionary integration or a distraction from picking winners is the open debate - and it is the reason the firm is watched as an experiment, not just an investor.
The company itself is compact relative to its ambitions: roughly 420 employees across six global offices, still run on the founding idea that operators make the best backers. The bet is that the next quarter-century of returns will come less from spotting the one app everyone wants and more from rebuilding the systems everyone needs.